Sign In
Buy AIM
$0.363
-0.0198 (-5.17%)
At Close: Jun 23, 2026
AIM ImmunoTech Issues Stockholder Update on the Potential Role of Ampligen for Use Against the Wuhan Coronavirus Epidemic
11:30am, Tuesday, 18'th Feb 2020
OCALA, FL / ACCESSWIRE / February 18, 2020 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral disea
INO, CRSP among premarket gainers
02:14pm, Thursday, 13'th Feb 2020
CounterPath (NASDAQ:CPAH) +49% on securing five-year deal with Vodafone Fiji to extend superior quality voice services to consumers.Alpha Pro Tech (NYSEMKT:APT) +29% as orders surge for Alpha Pro Te
OCALA, FL / ACCESSWIRE / February 12, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral
94 Biggest Movers From Yesterday
10:13am, Wednesday, 12'th Feb 2020
Gainers
Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) shares gained 78.5% to close at $3.66 after the company announced a license agreement with Zhejiang HaiChang Biotechnology....
AIM ImmunoTech Inc. (NYSE American: AIM) today announced the filing of three provisional patent applications related to its drug candidate Ampligen in the company’s efforts toward joining the global
OCALA, FL / ACCESSWIRE / February 11, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM) today announced the filing of three provisional patent applications related to its drug candidate Ampligen in the c
OCALA, FL / ACCESSWIRE / February 5, 2020 / AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancer
SDRL, FCEL among premarket gainers
02:17pm, Tuesday, 28'th Jan 2020
Ocean Bio-Chem (NASDAQ:OBCI) +80% as its subsidiary Star brite announces registered EPA product kills the Coronavirus.Happiness Biotech Group (NASDAQ:HAPP) +70% on sales of Cordyceps Mycelia product
Reviewing Autolus Therapeutics (NASDAQ:AUTL) & AIM ImmunoTech (NASDAQ:AIM)
06:52am, Saturday, 25'th Jan 2020
Autolus Therapeutics (NASDAQ:AUTL) and AIM ImmunoTech (NYSE:AIM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of t
Read This Before Selling AIM ImmunoTech Inc. (NYSEMKT:AIM) Shares
10:27am, Thursday, 16'th Jan 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
AIM ImmunoTech to Present at the Investor Summit in Philadelphia
05:20pm, Wednesday, 11'th Dec 2019
OCALA, FL / ACCESSWIRE / December 11, 2019 / AIM ImmunoTech Inc. (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancer
AIM ImmunoTech Issues Stockholder Update and Details Its Expectations for 2020
11:30am, Wednesday, 04'th Dec 2019
OCALA, FL / ACCESSWIRE / December 4, 2019 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and
CORRECTION: AIM ImmunoTech Provides Business Update for the Third Quarter of 2019
03:25pm, Friday, 15'th Nov 2019
The company had cash, cash equivalents and marketable securities of $1,825,000 as of December 31, 2018, not December 31, 2019. OCALA, FL / ACCESSWIRE / November 15, 2019 / AIM ImmunoTech (NYSE Americ
AIM ImmunoTech Provides Business Update for the Third Quarter of 2019
11:30am, Friday, 15'th Nov 2019
OCALA, FL / ACCESSWIRE / November 15, 2019 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and
AIM ImmunoTech to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
10:30am, Wednesday, 23'rd Oct 2019
OCALA, FL / ACCESSWIRE / October 23, 2019 / AIM ImmunoTech Inc. (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers
